InNexus Biotechnology, Inc.

InNexus Biotechnology, Inc.verified

IXSBF

Price:

$0.0001

Market Cap:

$17.52K

InNexus Biotechnology, Inc., a development stage company, engages in the commercialization of monoclonal antibodies based on its Dynamic Cross Linking (DXL) technology. Its DXL technology seeks to improve the therapeutic potency of existing monoclonal antibody products by increasing the binding to target antigen, enhancing antibody effector functions, and installing new properties into antibodies. The company's products in pipeline include DXL625, a monoclonal antibody in late stage pre-clinical development produced with enhanced binding kinetics and effector functions for the treatment of B cell non-Hodgkins lymphoma (NHL) and DXLr120, a recombinant DXL anti-CD20 antibody being developed fo...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2005-01-28

Stock Exchange

OTC

Ticker

IXSBF

The Enterprise Value as of November 2025 (TTM) for InNexus Biotechnology, Inc. (IXSBF) is 3.38M

According to InNexus Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.38M. This represents a change of -67.86% compared to the average of 10.52M of the last 4 quarters.

InNexus Biotechnology, Inc. (IXSBF) Historical Enterprise Value (quarterly & annually)

How has IXSBF Enterprise Value performed in the past?

The mean historical Enterprise Value of InNexus Biotechnology, Inc. over the last ten years is 7.93M. The current 3.38M Enterprise Value has changed 4.16% with respect to the historical average. Over the past ten years (40 quarters), IXSBF's Enterprise Value was at its highest in in the March 2007 quarter at 39.72M. The Enterprise Value was at its lowest in in the June 2001 quarter at 2.63M.

Quarterly (TTM)
Annual

Average

7.93M

Median

8.17M

Minimum

2.63M

Maximum

12.67M

InNexus Biotechnology, Inc. (IXSBF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of InNexus Biotechnology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 151.28%

Maximum Annual Enterprise Value = 12.67M

Minimum Annual Increase = -56.40%

Minimum Annual Enterprise Value = 2.63M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20105.93M-52.63%
200912.51M19.99%
200810.43M-17.72%
200712.67M11.07%
200611.41M151.28%
20054.54M-56.40%
200410.41M103.65%
20035.11M40.05%
20023.65M39.01%
20012.63M11.88%

InNexus Biotechnology, Inc. (IXSBF) Average Enterprise Value

How has IXSBF Enterprise Value performed in the past?

The current Enterprise Value of InNexus Biotechnology, Inc. (IXSBF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

9.62M

5-year avg

10.59M

10-year avg

7.93M

InNexus Biotechnology, Inc. (IXSBF) Enterprise Value vs. Peers

How is IXSBF’s Enterprise Value compared to its peers?

InNexus Biotechnology, Inc.’s Enterprise Value is greater than Biomagnetics Diagnostics Corp. (276.95K), less than Wellness Center USA, Inc. (4.00M), less than Vaxxinity, Inc. (10.87M), greater than PaxMedica, Inc. Common Stock (-4698079.00), greater than NovAccess Global Inc. (2.18M), greater than NanoLogix, Inc. (108.80K), less than ORHub, Inc. (8.51M), less than SmileDirectClub, Inc. (778.69M), less than VIA Pharmaceuticals, Inc. (13.93M), less than Strategic Partners A/S (35.45M),

Build a custom stock screener for InNexus Biotechnology, Inc. (IXSBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InNexus Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InNexus Biotechnology, Inc. (IXSBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InNexus Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is InNexus Biotechnology, Inc.'s Enterprise Value?

What is the highest Enterprise Value for InNexus Biotechnology, Inc. (IXSBF)?

What is the 3-year average Enterprise Value for InNexus Biotechnology, Inc. (IXSBF)?

What is the 5-year average Enterprise Value for InNexus Biotechnology, Inc. (IXSBF)?

How does the current Enterprise Value for InNexus Biotechnology, Inc. (IXSBF) compare to its historical average?